Jacqueline (Jackie) Tyler is a Technical Development Principal Scientist at Genentech, specializing in large molecule formulation development. Since 2021, they have been leading formulation strategy for tech transfers and overseeing the development of antibody drug products in preparation for commercial launch. Jackie has previously worked as an engineer across various roles at Genentech, contributing significantly to Phase III clinical trials and regulatory filings. They hold a Master of Science in Biomedical/Medical Engineering from Purdue University, where they also completed their undergraduate degree in the same field.
This person is not in any teams
This person is not in any offices